THOMAS PAUL 4
4 · Axogen, Inc. · Filed Jun 26, 2026
Research Summary
AI-generated summary of this filing
Axogen (AXGN) Director Thomas Paul Receives Award
What Happened
- Thomas Paul, a member of Axogen’s Board of Directors, received a grant of 5,579 restricted stock units (RSUs) on June 24, 2026. The filing reports a $0.00 per-share acquisition price because this was an equity award rather than an open-market purchase. The grant is reported with an approximate total value of $235,000 based on the company’s valuation for director compensation.
Key Details
- Transaction date: June 24, 2026; Form 4 filed June 26, 2026.
- Award: 5,579 RSUs at $0.00 per share (derivative award).
- Estimated grant value: $235,000 (per footnote describing the valuation used to set the award).
- Vesting: RSUs vest on June 24, 2027 (one-year cliff), per footnote.
- What RSUs mean: Each RSU represents a contingent right to receive one share of Axogen common stock upon vesting (footnote F1).
- Shares owned after transaction: Not disclosed in the filing.
Context
- This is an annual director equity grant for service on the Board (routine compensation, not a market purchase or sale). RSUs are not immediate stock — they convert to shares only if and when they vest, and therefore do not represent currently tradeable shares.
Insider Transaction Report
Form 4
Axogen, Inc.AXGN
THOMAS PAUL
Director
Transactions
- Award
Restricted Stock Units
[F1][F2]2026-06-24+5,579→ 5,579 total→ Common Stock (5,579 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.
- [F2]Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $235,000 valuation as of the grant date and vests on June 24, 2027, the one-year anniversary of the grant date.
Signature
/s/ Marc Began, as attorney-in-fact for Paul Thomas|2026-06-26